NYSE: CLXClorox Co Stock
$145.97+0.83 (+0.57%)
Updated Apr 23, 2024
CLX Price
$145.97
Fair Value Price
N/A
Market Cap
$18.12B
52 Week Low
$114.69
52 Week High
$178.21
P/E
228.08x
P/B
341.81x
P/S
2.42x
PEG
1.69x
Dividend Yield
4.1%
Revenue
$7.31B
Earnings
$80.00M
Gross Margin
41.9%
Operating Margin
3.23%
Profit Margin
1.1%
Debt to Equity
107.36
Operating Cash Flow
$944M
Beta
0.31
Next Earnings
Apr 30, 2024
Ex-Dividend
Apr 23, 2024
Next Dividend
May 10, 2024
CLX Overview
The Clorox Company manufactures and sells a variety of consumer staples products, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal-care products. Clorox products are sold primarily through mass merchandisers, retail outlets, e-commerce channels, distributors, and medical supply providers under the Burt's Bees, Formula 409, Glad, Hidden Valley, Kingsford, Kitchen Bouquet, KC Masterpiece, and other brands. The company was founded in 1913 and is headquartered in Oakland, CA.
Zen Score
–
Industry Average (36)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CLX scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CLX ($145.97) is trading above its intrinsic value of $33.83, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CLX is poor value based on its earnings relative to its share price (228.08x), compared to the US market average (41.92x)
P/E vs Market Valuation
CLX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CLX due diligence checks available for Premium users.
Be the first to know about important CLX news, forecast changes, insider trades & much more!
CLX News
Valuation
CLX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
228.08x
Industry
35.55x
Market
41.92x
CLX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CLX is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
CLX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
341.81x
Industry
7.31x
CLX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CLX price to earnings growth (PEG)
For valuing profitable companies with growth potential
CLX is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
CLX's financial health
Profit margin
Revenue
$2.0B
Net Income
$93.0M
Profit Margin
4.7%
CLX's Earnings (EBIT) of $236.00M... subscribe to Premium to read more.
Interest Coverage Financials
CLX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$5.9B
Liabilities
$5.7B
Debt to equity
107.36
CLX's short-term liabilities ($2.02B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CLX's long-term liabilities ($3.67B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CLX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CLX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$153.0M
Investing
-$33.0M
Financing
-$259.0M
CLX's operating cash flow ($944.00M)... subscribe to Premium to read more.
Debt Coverage Financials
CLX vs Household & Personal Product Stocks
Clorox Co Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.